Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation

Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation

Introduction: Approximately 80% of individuals with multiple sclerosis (MS) have a positive response to autologous hematopoietic stem cell transplantation (aHSCT). Markers that may predict the transplant outcome are necessary. The objective of this work is to identify markers that may refine the sel...

Full description

Saved in:
Bibliographic Details
Main Authors: Moisés Manuel Gallardo-Pérez, Alejandro Ruiz-Argüelles, Guillermo José Ruiz-Argüelles, Virginia Reyes-Núñez, Silvia Soto-Olvera, Solón Javier Garcés-Eisele
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Sclerosis
Subjects:
biomarkers
multiple sclerosis
auto-HSCT
Online Access:https://www.mdpi.com/2813-3064/3/2/9
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.mdpi.com/2813-3064/3/2/9

Similar Items